Sirpiglenastat API Manufacturers
compare suppliers & get competitive offers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Sirpiglenastat is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Sirpiglenastat or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Sirpiglenastat API 2079939-05-0?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Sirpiglenastat. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Sirpiglenastat
- Synonyms:
- (-)-sirpiglenastat , (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate , L-norleucine, n-acetyl-l-tryptophyl-6-diazo-5-oxo-, 1-methylethyl ester , Propan-2-yl (2s)-2-((n-acetyl-l-tryptophyl)amino)-6-diazo-5-oxohexanoate
- Cas Number:
- 2079939-05-0
- DrugBank number:
- DB17536
- Unique Ingredient Identifier:
- 9GGE6A0ZMK
General Description:
Sirpiglenastat, identified by CAS number 2079939-05-0, is a notable compound with significant therapeutic applications. Sirpiglenastat, also known as DRP-104, is a prodrug of (DON), which is a broad-acting glutamine antagonist. It is under investigation in clinical trial NCT04471415 (Study to Investigate DRP-104 in Adults With Advanced Solid Tumors).
